| 产品详情 |
| Edit |   |
| Product Name | 2-[(2S,3S)-3-[(4R)-4-(1,1-Dimethylethyl)-2,5-dioxo-1-imidazolidinyl]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazide N-(Methoxycarbonyl)-3-methyl-L-valine((Atazanavir Cyclization product (western half) |
| Description | 2-[(2S,3S)-3-[(4R)-4-(1,1-Dimethylethyl)-2,5-dioxo-1-imidazolidinyl]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazide N-(Methoxycarbonyl)-3-methyl-L-valine, is an impurity of the drug Atazanavir (A790051), a novel azapeptide HIV protease inhibitor (PI). Antiviral. Molecular Formula: C37H48N6O6 Molecular Weight: 672.81 |
| Size | 1mg, 5mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | 414483 |
| Price | |
| Order / More Info | 2-[(2S,3S)-3-[(4R)-4-(1,1-Dimethylethyl)-2,5-dioxo-1-imidazolidinyl]-2-hydroxy-4-phenylbutyl]-2-[[4-(2-pyridinyl)phenyl]methyl]hydrazide N-(Methoxycarbonyl)-3-methyl-L-valine((Atazanavir Cyclization product (western half) from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|